Search
for
Sort by
Research 631–660 of 1000+
- Expression and Function of FGF5 Isoform in Hair Growth
- In vivo Pharmacokinetic Interactions of Finasteride and Identification of Novel Metabolites
- Cutaneous Clues in Systemic Disease: The Role of Dermatological Manifestations in Internal Medicine and Endocrinology
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Minoxidil as a Prodrug: Review of Chemical, Pharmacological, and Technological Aspects in Alopecia Therapeutics
- HORMONE THERAPIES: SCIENTIFIC EVIDENCE BASED ON EVIDENCE AND INDISCRIMINATE USE
- Bioavailability File: Bicalutamide
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Comprehensive Management of Polycystic Ovary Syndrome: The Role of Metformin in Addressing Metabolic and Endocrine Dysregulation
- Prepregnancy Phenotype and Physiological Characteristics in PCOS
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Pre‐ and Paraneoplastic Syndromes
- Maladies systémiques associées à la cirrhose biliaire primitive : à propos de 10 cas
- Finasteride Side Effects
- Finasteride Reduces Total Cholesterol in LDLR-Deficient Mice
- Disrupted Pancreatic Exocrine Differentiation and Malabsorption in Response to Chronic Elevated Systemic Glucocorticoid
- Keratin 79 is a PPARA target that is highly expressed by liver damage
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
- Esomeprozole-Induced Hepatitis
- Mechanisms of hepatocyte attachment to keratin biomaterials
- Metabolite screening of aromatic amine hair dyes using<i>in vitro</i>hepatic models
- Apparent Cortisone Reductase Deficiency: A Rare Cause of Hyperandrogenemia and Hypercortisolism
- In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug–drug interactions
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Finasteride and Methadone Use and Risk of Advanced Hepatitis C Related Liver Disease
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway
- Woodhouse-Sakati Syndrome with Unique Unreported Previous Findings
- PROTECTIVE EFFECT OF METHANOL EXTRACT OF RUSSELIA EQUISETIFORMIS AGAINST PARACETAMOL-INDUCED HEPATOTOXICITY IN WISTAR RATS